Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil
Author(s) -
Simone Ladeia-Andrade,
Maria José Menezes,
Taís Nóbrega de Sousa,
Ana Carolina Rios Silvino,
Jaques F. de Carvalho,
Laís Camoese Salla,
Odailton Amaral Nery,
Gladson Naber P. de Melo,
Rodrigo M. Corder,
Priscila T. Rodrigues,
Marcelo U. Ferreira
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01965-18
Subject(s) - primaquine , chloroquine , malaria , plasmodium vivax , vivax malaria , plasmodium falciparum , piperaquine , drug resistance , medicine , virology , artemisinin , biology , pharmacology , immunology , microbiology and biotechnology
EmergingPlasmodium vivax resistance to chloroquine (CQ) may undermine malaria elimination efforts in South America. CQ-resistantP. vivax has been found in the major port city of Manaus but not in the main malaria hot spots across the Amazon Basin of Brazil, where CQ is routinely coadministered with primaquine (PQ) for radical cure of vivax malaria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom